Narcolepsy in Saudi Arabia. Demographic and clinical perspective of an under-recognized disorder

Saudi Medical Journal

Volumn 27, Issue 9, 2006, Pages 1352-1387

  BaHammam, Ahmed S ^a   Alenezi, Ahmed M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; FLUOXETINE; IMIPRAMINE; METHYLPHENIDATE; MODAFINIL;

ADOLESCENT; ADULT; AGED; ARTICLE; BEHAVIOR THERAPY; CATAPLEXY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; GINGIVITIS; HEADACHE; HUMAN; IMPOTENCE; MALE; NARCOLEPSY; POLYSOMNOGRAPHY; SAUDI ARABIA; SCHOOL CHILD; SYMPTOM;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; CLOMIPRAMINE; FEMALE; FLUOXETINE; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; NARCOLEPSY; POLYSOMNOGRAPHY; SAUDI ARABIA;

EID: 33748876557     PISSN: 03795284     EISSN: 03795284     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gelineau JB. De la narcolepsie. Gaz des Hop (Paris) 1880; 53:626-628.
2. Soloman P. Narcolepsy in negros. Dis Nerv Syst 1945; 6:179-183.
3. Dement WC, Carskadon M, Ley R. The prevalence of narcolepsy. J Sleep Res 1973; 2:147.
4. Dement WC, Zarcone Y, Vaener V. The prevalence of narcolepsy. J Sleep Res 1972; 1: 148.
5. Honda Y. Census of narcolepsy, cataplexy and sleep life among teen-agers in Fugisawa city. J Sleep Res 1979; 8:191.
6. Lavie P, Peled R. Narcolepsy is a rare disease in Israel. Sleep 1987; 10:608-609.
7. Al Rajeh S, Bademosi O, Ismail H, Awada A, Dawodu A, Al-Freihi H, et al. A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology 1993;12:164-178.
8. Silber MH, Krahn LE, Pankratz VS. The epidemiology of narcolepsy in the Olmstead county, Minnesota: a population based study. Sleep 2002; 25:197-202.
9. Choo KL, Guilleminault C. Narcolepsy and idiopathic hypersomnia. Clin Chest Med 1998; 19:169-181.
10. Zeman A, Britton T, Douglas N, et al. Narcolepsy and excessive daytime sleepiness. BMJ 2004; 724-728.
11. Melberg A, Ripley B, Lin L, Hetta J, Mignot E, Nishino S. Hypocretin defciency in familial symptomatic narcolepsy. Ann Neurol 2001; 49:136-137.
12. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, et al. Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001; 68:686-699.
13. Mignot E, Thorsby E. Narcolepsy and the HLA system. N Eng J Med 2001; 344:692.
14. Wise MS. Childhood narcolepsy. Neurology 1998; 50 (suppl 1): S37-S42.
15. American Academy of Sleep Medicine. International classifcation of sleep disorders, revised: diagnostic and coding manual. Rochester, MN: American Academy of Sleep Medicine; 2001.
16. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-545.
17. Rechtschaffen A, Kales A, editors. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. NIH publication #204. Washington, DC: US Government Printing Offce; 1968.
18. American Sleep Disorders Association, Atlas Task Force. EEG arousals: scoring rules and examples. Sleep 1992; 15: 174-184.
19. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault C, editor. Sleep and waking disorders. Menlo Park: Addison-Wesley; 1982. p. 265-295.
20. Thorpy MJ, Westbrook P, Ferber R, Fredrickson P, Mahowald M, Perez-Guerra F, et al. The clinical use of the multiple sleep latency test. An American Sleep Disorders Association report. Sleep 1992; 15: 268-276.
21. Kryger MH, Walld R, Manfreda J. Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist. Sleep 2001; 25: 36-41.
22. Yoss RE, Daly DD. Criteria for the diagnosis of the narcoleptic syndrome. Mayo Clin Proc 1957; 12; 320-328.
23. Passouant P, Billiard M. The evolution of narcolepsy with age. In: Guilleminault C, Dement WC, Passouant P, editors. Narcolepsy. New York: Spectrum; 1976. p.179-196.
24. Guilleminault C, Mignot E, Partinen M. Controversies in the diagnosis of narcolepsy. Sleep 1994; 17 (8 Suppl): S1-S6.
25. Aldrich MS. Diagnostic aspects of narcolepsy. Neurology 1998; 52: S2-S7.
26. Aldrich MS. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Neurology 1996; 46: 393-401.
27. Carskadon MS, Dement WC. Normal human sleep: an overview. In: Kryger MH, Roth T, Dement WC, editors. Principles and Practice of Sleep Medicine. Philadelphia: Saunders; 1994. p. 16-25.
28. Broughton RJ, Fleming JA, George CF, Hill JD, Kryger MH, Moldofsky H, et al. Randomized, double-blind, placebo-controlled crossover trial of modafnil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997; 49: 444-451.
29. Stores G, Crawford C. Medical student education in sleep and its disorders. J R Coll Physicians Lond 1998; 32: 149-153.
30. BaHammam AS. Knowledge and Attitude of Primary Health care Physicians towards Sleep Disorders. Saudi Med J 2000; 21: 1164-1167.
31. Daly DD, Yoss RE. The treatment of narcolepsy with methyl phenylpiperidylacetate: a preliminary report. Mayo Clin Proc 1956; 31: 620-625.
32. Robertson P Jr, Hellriegel ET. Clinical pharmacokinetic profle of modafnil. Clin Pharmacokinet 2003; 42: 123-137.